Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunovant, Inc.

15.80
-0.0600-0.38%
Post-market: 15.800.00000.00%17:04 EDT
Volume:1.91M
Turnover:30.09M
Market Cap:2.70B
PE:-5.79
High:16.04
Open:16.04
Low:15.44
Close:15.86
Loading ...
Jun 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 29, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
May 29, 2025

Major Issues Report

Form 8-K - Current report
May 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 01, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Apr 21, 2025

Major Issues Report

Form 8-K - Current report
Mar 19, 2025

Major Issues Report

Form 8-K - Current report
Mar 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 06, 2025

Major Issues Report

Form 8-K - Current report
Feb 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jan 24, 2025

Major Issues Report

Form 8-K - Current report
Jan 14, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]